Financhill
Sell
36

VLY Quote, Financials, Valuation and Earnings

Last price:
$8.89
Seasonality move :
0.49%
Day range:
$8.72 - $8.92
52-week range:
$6.47 - $11.10
Dividend yield:
5.05%
P/E ratio:
12.62x
P/S ratio:
2.47x
P/B ratio:
0.68x
Volume:
5.7M
Avg. volume:
10.7M
1-year change:
18.67%
Market cap:
$4.9B
Revenue:
$1.8B
EPS (TTM):
$0.69

VLY Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for Valley National Bancorp shares anticipate an average target of $10.44, ranging from a low estimate of $9.50 to a high estimate of $11.00. This average target implies a growth of 19.91% compared to the current stock price of $8.71.

Consensus Price Target

$10.44

Highest Price Target

$11.00

Lowest Price Target

$9.50

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 2 2 2

Hold 7 5 5

Sell 0 0 0
Consensus Hold Hold Hold

VLY Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Adobe Stock a Bargain With AI Tools Driving Growth?
Is Adobe Stock a Bargain With AI Tools Driving Growth?

The share price of American computer software company Adobe (NASDAQ:ADBE)…

Is Palantir Stock a Millionaire Maker?
Is Palantir Stock a Millionaire Maker?

Palantir (NASDAQ:PLTR) has shot upward over the last year and…

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
4
CABO alert for May 3

Cable One [CABO] is down 41.98% over the past day.

Buy
55
PDEX alert for May 3

Pro-Dex [PDEX] is down 32.02% over the past day.

Buy
60
RGC alert for May 3

Regencell Bioscience Holdings [RGC] is down 22.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock